These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8349857)

  • 1. Cultured keratinocyte allografts and wound healing in severe recessive dystrophic epidermolysis bullosa.
    McGrath JA; Schofield OM; Ishida-Yamamoto A; O'Grady A; Mayou BJ; Navsaria H; Leigh IM; Eady RA
    J Am Acad Dermatol; 1993 Sep; 29(3):407-19. PubMed ID: 8349857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa.
    Siprashvili Z; Nguyen NT; Gorell ES; Loutit K; Khuu P; Furukawa LK; Lorenz HP; Leung TH; Keene DR; Rieger KE; Khavari P; Lane AT; Tang JY; Marinkovich MP
    JAMA; 2016 Nov; 316(17):1808-1817. PubMed ID: 27802546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological and molecular restoration of type VII collagen in Recessive dystrophic epidermolysis bullosa mouse skin by topical injection of keratinocyte-like cells differentiated from human adipose-derived mesenchymal stromal cells.
    Matsuda A; Hasegawa T; Ikeda Y; Wada A; Ikeda S
    J Dermatol Sci; 2024 Jul; 115(1):42-50. PubMed ID: 38876908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa.
    Venugopal SS; Yan W; Frew JW; Cohn HI; Rhodes LM; Tran K; Melbourne W; Nelson JA; Sturm M; Fogarty J; Marinkovich MP; Igawa S; Ishida-Yamamoto A; Murrell DF
    J Am Acad Dermatol; 2013 Dec; 69(6):898-908.e7. PubMed ID: 24075228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa.
    So JY; Nazaroff J; Iwummadu CV; Harris N; Gorell ES; Fulchand S; Bailey I; McCarthy D; Siprashvili Z; Marinkovich MP; Tang JY; Chiou AS
    Orphanet J Rare Dis; 2022 Oct; 17(1):377. PubMed ID: 36253825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients.
    Woodley DT; Cogan J; Hou Y; Lyu C; Marinkovich MP; Keene D; Chen M
    J Clin Invest; 2017 Aug; 127(8):3028-3038. PubMed ID: 28691931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of induced pluripotent stem cell-derived mesenchymal stem/stromal cells from normal human and RDEB epidermal keratinocytes.
    Nakayama C; Fujita Y; Matsumura W; Ujiie I; Takashima S; Shinkuma S; Nomura T; Abe R; Shimizu H
    J Dermatol Sci; 2018 Sep; 91(3):301-310. PubMed ID: 29933899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular expression of type VII collagen during wound healing in severe recessive dystrophic epidermolysis bullosa and normal human skin.
    McGrath JA; Leigh IM; Eady RA
    Br J Dermatol; 1992 Oct; 127(4):312-7. PubMed ID: 1419750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recessive dystrophic epidermolysis bullosa skin displays a chronic growth-activated immunophenotype. Implications for carcinogenesis.
    Smoller BA; McNutt NS; Carter DM; Gottlieb AB; Hsu A; Krueger J
    Arch Dermatol; 1990 Jan; 126(1):78-83. PubMed ID: 1688702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual mechanism of type VII collagen transfer by bone marrow mesenchymal stem cell extracellular vesicles to recessive dystrophic epidermolysis bullosa fibroblasts.
    McBride JD; Rodriguez-Menocal L; Candanedo A; Guzman W; Garcia-Contreras M; Badiavas EV
    Biochimie; 2018 Dec; 155():50-58. PubMed ID: 29653141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of intractable skin ulcers in recessive dystrophic epidermolysis bullosa patients to an allogeneic cultured dermal substitute.
    Natsuga K; Sawamura D; Goto M; Homma E; Goto-Ohguchi Y; Aoyagi S; Akiyama M; Kuroyanagi Y; Shimizu H
    Acta Derm Venereol; 2010 Mar; 90(2):165-9. PubMed ID: 20169300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cord blood-derived unrestricted somatic stem cells promote wound healing and have therapeutic potential for patients with recessive dystrophic epidermolysis bullosa.
    Liao Y; Itoh M; Yang A; Zhu H; Roberts S; Highet AM; Latshaw S; Mitchell K; van de Ven C; Christiano A; Cairo MS
    Cell Transplant; 2014 Mar; 23(3):303-17. PubMed ID: 23394106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal aspects of type VII collagen: Implications for dystrophic epidermolysis bullosa and epidermolysis bullosa acquisita.
    Watanabe M; Natsuga K; Shinkuma S; Shimizu H
    J Dermatol; 2018 May; 45(5):515-521. PubMed ID: 29352483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of skin equivalents for gene therapy of recessive dystrophic epidermolysis bullosa.
    Gache Y; Baldeschi C; Del Rio M; Gagnoux-Palacios L; Larcher F; Lacour JP; Meneguzzi G
    Hum Gene Ther; 2004 Oct; 15(10):921-33. PubMed ID: 15585108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathomechanisms of Altered Wound Healing in Recessive Dystrophic Epidermolysis Bullosa.
    Cianfarani F; Zambruno G; Castiglia D; Odorisio T
    Am J Pathol; 2017 Jul; 187(7):1445-1453. PubMed ID: 28460207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of dystrophic epidermolysis bullosa with autologous meshed split-thickness skin grafts and allogeneic cultured keratinocytes.
    Verplancke P; Beele H; Monstrey S; Naeyaert JM
    Dermatology; 1997; 194(4):380-2. PubMed ID: 9252770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation of autologous single hair units heals chronic wounds in autosomal recessive dystrophic epidermolysis bullosa: A proof-of-concept study.
    Wong TW; Yang CC; Hsu CK; Liu CH; Yu-Yun Lee J
    J Tissue Viability; 2021 Feb; 30(1):36-41. PubMed ID: 33199167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa.
    Conget P; Rodriguez F; Kramer S; Allers C; Simon V; Palisson F; Gonzalez S; Yubero MJ
    Cytotherapy; 2010 May; 12(3):429-31. PubMed ID: 20230217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune tolerance of allogeneic haematopoietic cell transplantation supports donor epidermal grafting of recessive dystrophic epidermolysis bullosa chronic wounds.
    Ebens CL; McGrath JA; Riedl JA; Keith AR; Lilja G; Rusch S; Keene DR; Tufa SF; Riddle MJ; Shanley R; Van Heest AE; Tolar J
    Br J Dermatol; 2021 Jun; 184(6):1161-1169. PubMed ID: 32866988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of wound care options in patients with recessive dystrophic epidermolysis bullosa: a costly necessity.
    Kirkorian AY; Weitz NA; Tlougan B; Morel KD
    Pediatr Dermatol; 2014; 31(1):33-7. PubMed ID: 24224977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.